Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice

Hans E. Johnsen, Corrine Haioun, Pieternella J. Lugtenburg, Antonio Salar, Ulrich Jaeger, Ruth Pettengell, Francesca G. Rossi, Gregor Verhoef, Matthias Schwenkglenks, Kate Bendall, Ulrich Duehrsen

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)982-984
Number of pages3
JournalLeukemia and Lymphoma
Issue number5
Publication statusPublished - May 2012

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this